PIAS2 Recombinant Antibody, Cy3 Conjugated
Product Specifications
Background
Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor. Plays a crucial role as a transcriptional coregulator in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway.
Synonyms
DIP; MIZ; MIZ1; SIZ2; ARIP3; PIASX; ZMIZ4; PIASX-BETA; PIASX-ALPHA.
Gene ID
9063
Swiss Prot
O75928
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
PIAS2
Clonality
Recombinant
Conjugation
Cy3
Source
KLH conjugated synthetic peptide derived from human PIAS2
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
512,550nm/570,615nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
9063
Isotype
IgG
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS4380674-01 0.02 mg (With BSA & Azide at 0.2mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details 
MBS4380674-02 0.1 mg (With BSA & Azide at 0.2mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details 
MBS4380674-03 0.1 mg (Without BSA & Azide at 1mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details MBS4380674-04 5x 0.1 mg (With BSA & Azide at 0.2mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details 
MBS4380674-05 5x 0.1 mg (Without BSA & Azide at 1mg/mL)
RAD51 (Prognostic and Response to Chemotherapy Marker)
Ask
View Details MBS7082668 Inquire
Recombinant Pan troglodytes 5-hydroxytryptamine receptor 2C (HTR2C), partial
Ask
View Details